Seelos Therapeutics, Inc. Stock
Stocks
SEELQ
US81577F4063
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
0.00% | - |
| Dec. 28 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 25-10-21 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
| Market Cap | 101K 88.8K 81.85K 76.63K 144K 9.55M 147K 984K 381K 4.72M 380K 372K 16.37M | P/E 2022 |
-0.98x | P/E 2023 | -0.18x |
|---|---|---|---|---|---|
| Enterprise Value | 11.33M 9.94M 9.16M 8.58M 16.08M 1.07B 16.41M 110M 42.6M 528M 42.56M 41.63M 1.83B | EV / Sales 2022 |
-
| EV / Sales 2023 | 11,278,456x |
| Free-Float |
88.85% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +9,900.00% |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.01 | |
| 1 year | 0 | 0.01 | |
| 3 years | 0 | 6,374.41 | |
| 5 years | 0 | 11,904.01 | |
| 10 years | 0 | 28,761.63 |
| Manager | Title | Age | Since |
|---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 66 | 2018-12-31 |
| Director of Finance/CFO | 54 | 2021-08-31 | |
Gopal Krishna
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-02-28 | Free | Chief Financial Officer | 417 | 0.0043% | ||
| 24-01-11 | Free | Chief Executive Officer | 70,383 | 0.7186% | ||
| 24-01-11 | Free | Chief Financial Officer | 24,537 | 0.2505% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9,900.00% | 0.00% | - | -100.00% | 136 | ||
| +0.33% | +1.37% | +64.03% | +119.11% | 55.63B | ||
| +0.82% | +15.05% | +79.93% | +84.34% | 52.25B | ||
| +1.36% | +0.36% | -14.06% | -14.69% | 23.07B | ||
| -1.04% | +7.91% | +1.61% | +419.24% | 22.41B | ||
| -0.18% | +7.20% | +32.16% | -14.07% | 17.32B | ||
| -1.10% | +4.00% | +28.70% | -34.51% | 15.94B | ||
| -3.35% | +8.96% | +132.20% | +290.18% | 13.47B | ||
| +2.89% | +5.51% | +27.11% | +181.45% | 13.77B | ||
| +1.31% | +0.53% | +28.62% | - | 12.43B | ||
| Average | +990.10% | +4.30% | +42.26% | +103.45% | 22.63B | |
| Weighted average by Cap. | +0.26% | +5.13% | +48.50% | +120.17% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | 2.2 1.93 1.78 1.67 3.13 207.81 3.19 21.4 8.28 102.71 8.27 8.09 356.14 |
| Net income | -73.53M -64.47M -59.43M -55.64M -104M -6.94B -106M -714M -276M -3.43B -276M -270M -11.89B | -37.88M -33.21M -30.62M -28.66M -53.75M -3.57B -54.86M -368M -142M -1.77B -142M -139M -6.12B |
| Net Debt | 4.59M 4.02M 3.71M 3.47M 6.51M 433M 6.65M 44.58M 17.25M 214M 17.23M 16.86M 742M | 11.23M 9.85M 9.08M 8.5M 15.94M 1.06B 16.27M 109M 42.22M 524M 42.18M 41.26M 1.82B |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | $0.000000 | - | 1 |
| 26-06-25 | $0.000000 | - | 3 |
| 26-06-24 | $0.000000 | - | 2 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SEELQ Stock
Select your edition
All financial news and data tailored to specific country editions
















